Skip to search formSkip to main contentSkip to account menu

111In-diDTPA-FKYK

Known as: 111In-diDTPA-Phe-Lys-Tyr-Lys, 111In-diethylenetriaminepentaacetic acid-FKYK 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

OligopeptidesPentetic Acid
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
UNLABELLED We have developed an efficient pretargeting strategy for renal cell carcinoma (RCC) based on a biologically produced… 
2005
2005
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
UNLABELLED Previous studies have shown that pretargeting allows rapid visualization of renal cell carcinomas (RCC) with an (111… 
Highly Cited
1999
Highly Cited
1999
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Radiolabeled monoclonal antibodies (mAbs) can target tumors selectively. Sustained activity levels in nontarget tissues limit… 
Highly Cited
1993
Highly Cited
1993
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
Two-step radioimmunotargeting using a bispecific anti-CEA/anti-in-DTPA monoclonal antibody and an 111In-labeled DTPA dimer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)